{"transactions":[{"id":2111522,"issuer":{"id":122292,"kind":"organization","name":"LogicBio Therapeutics, Inc.","symbol":"LOGC"},"owners":[{"id":67760,"kind":"person","name":"Chen Leon","position":1,"cik":"0001752432","reported_name":"Chen Leon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-17T21:04:58.000Z","date":"2022-11-16","kind":"disposition_to_issuer","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each option was cancelled pursuant to the terms of the Merger Agreement; provided, that each option with a per share exercise price equal to or greater than $2.07 was automatically cancelled for no consideration. For more information see the Solicitation/Recommendation Statement on Schedule 14D-9 filed by the Company with the United States Securities and Exchange Commission on October 18, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options were granted on June 17, 2022. The options were scheduled to vest in full on the earlier of (i) the first anniversary of the grant date, and (ii) the day prior to the Company's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service with the Company on the vesting date."}],"balance_after":0,"derivative":{"exercise_price":0.38,"expiration_date":"2032-06-17","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-22-036292","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1664106/000089924322036292/doc4.xml","form_type":"4"}},{"id":2111521,"issuer":{"id":122292,"kind":"organization","name":"LogicBio Therapeutics, Inc.","symbol":"LOGC"},"owners":[{"id":67760,"kind":"person","name":"Chen Leon","position":1,"cik":"0001752432","reported_name":"Chen Leon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-17T21:04:58.000Z","date":"2022-11-16","kind":"disposition_to_issuer","acquired":false,"shares":44508,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each option was cancelled pursuant to the terms of the Merger Agreement; provided, that each option with a per share exercise price equal to or greater than $2.07 was automatically cancelled for no consideration. For more information see the Solicitation/Recommendation Statement on Schedule 14D-9 filed by the Company with the United States Securities and Exchange Commission on October 18, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were fully vested as of June 19, 2021."}],"balance_after":0,"derivative":{"exercise_price":0.73,"expiration_date":"2027-11-02","underlying":"Common Stock","underlying_shares":44508},"source":{"system":"sec-edgar","filing":"0000899243-22-036292","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1664106/000089924322036292/doc4.xml","form_type":"4"}},{"id":2111520,"issuer":{"id":122292,"kind":"organization","name":"LogicBio Therapeutics, Inc.","symbol":"LOGC"},"owners":[{"id":67760,"kind":"person","name":"Chen Leon","position":1,"cik":"0001752432","reported_name":"Chen Leon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-17T21:04:58.000Z","date":"2022-11-16","kind":"disposition_to_issuer","acquired":false,"shares":22333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 3, 2022 (the \"Merger Agreement\"), by and among LogicBio Therapeutics, Inc. (the \"Company\"), Alexion Pharmaceuticals, Inc. (\"Parent\") and Camelot Merger Sub, Inc. (\"Merger Sub\"), on November 16, 2022 (the \"Effective Time\"), Merger Sub merged with and into the Company (the \"Merger\"), with the Company continuing as the surviving corporation in the Merger and as a wholly-owned subsidiary of Parent, and, at the Effective Time, each share of common stock, par value $0.0001 per share, of the Company was cancelled and converted into the right to receive $2.07 in cash, without interest, less any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-036292","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664106/000089924322036292/doc4.xml","form_type":"4"}},{"id":2224852,"issuer":{"id":122292,"kind":"organization","name":"LogicBio Therapeutics, Inc.","symbol":"LOGC"},"owners":[{"id":67760,"kind":"person","name":"Chen Leon","position":1,"cik":"0001752432","reported_name":"Chen Leon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-21T08:00:12.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The options were granted by LogicBio Therapeutics, Inc. (the \"Company\") pursuant to its 2018 Equity Incentive Plan, as provided under the Company's current non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the earlier of (i) the first anniversary of the grant date, and (ii) the day prior to the Company's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service with the Company on the vesting date."}],"balance_after":12500,"derivative":{"exercise_price":0.38,"expiration_date":"2032-06-17","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-22-038232","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664106/000120919122038232/doc4.xml","form_type":"4"}},{"id":2669618,"issuer":{"id":122292,"kind":"organization","name":"LogicBio Therapeutics, Inc.","symbol":"LOGC"},"owners":[{"id":67760,"kind":"person","name":"Chen Leon","position":1,"cik":"0001752432","reported_name":"Chen Leon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-14T20:00:58.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted by the Issuer pursuant to its 2018 Equity Incentive Plan as provided under the Company's compensation policy for non-employee directors. All of the options will vest and become exercisable on the earlier of (i) the first anniversary of the grant date, and (ii) the day prior to the Company's 2022 annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer through the vesting date."}],"balance_after":12500,"derivative":{"exercise_price":4.59,"expiration_date":"2031-06-11","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-040428","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664106/000120919121040428/doc4.xml","form_type":"4"}},{"id":2698261,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":67760,"kind":"person","name":"Chen Leon","position":1,"cik":"0001752432","reported_name":"Chen Leon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2021-05-24T23:48:03.000Z","date":"2021-05-06","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 6, 2022, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Reporting Person is a partner of The Column Group which invests through The Column Group II, LP (\"TCG II LP\"), Ponoi Capital, LP (\"Ponoi LP\") and Ponoi Capital II, LP (\"Ponoi II LP,\" and together with TCG II LP and Ponoi LP, the \"Funds\"), among other entities. Under the partnership agreements of the Funds, the Reporting Person is deemed to hold the stock option for the economic benefit of the Funds. The Funds may be deemed indirect beneficial owners of the stock option. The Reporting Person disclaims beneficial ownership of the stock option except to the extent of his pecuniary interest therein."}],"balance_after":17500,"derivative":{"exercise_price":27.38,"expiration_date":"2031-05-05","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-21-035535","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1549595/000120919121035535/doc4.xml","form_type":"4"}},{"id":2924881,"issuer":{"id":122292,"kind":"organization","name":"LogicBio Therapeutics, Inc.","symbol":"LOGC"},"owners":[{"id":67760,"kind":"person","name":"Chen Leon","position":1,"cik":"0001752432","reported_name":"Chen Leon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-01-04T19:00:12.000Z","date":"2021-01-01","kind":"exercise","acquired":false,"shares":3298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represented a contingent right to receive one share of common stock of LogicBio Therapeutics, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the RSUs vested on January 1, 2021, subject to the terms and conditions of the award and the Company's 2018 Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"All of the RSUs vested on January 1, 2021, subject to the terms and conditions of the award and the Company's 2018 Plan."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3298},"source":{"system":"sec-edgar","filing":"0001209191-21-000519","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1664106/000120919121000519/doc4.xml","form_type":"4"}},{"id":2924880,"issuer":{"id":122292,"kind":"organization","name":"LogicBio Therapeutics, Inc.","symbol":"LOGC"},"owners":[{"id":67760,"kind":"person","name":"Chen Leon","position":1,"cik":"0001752432","reported_name":"Chen Leon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-04T19:00:12.000Z","date":"2021-01-01","kind":"exercise","acquired":true,"shares":3298,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represented a contingent right to receive one share of common stock of LogicBio Therapeutics, Inc. (the \"Company\")."}],"balance_after":3298,"source":{"system":"sec-edgar","filing":"0001209191-21-000519","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664106/000120919121000519/doc4.xml","form_type":"4"}},{"id":3101475,"issuer":{"id":122292,"kind":"organization","name":"LogicBio Therapeutics, Inc.","symbol":"LOGC"},"owners":[{"id":67760,"kind":"person","name":"Chen Leon","position":1,"cik":"0001752432","reported_name":"Chen Leon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-23T20:00:15.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":3298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the RSUs will vest on January 1, 2021, subject to the terms and conditions of the award and the Company's 2018 Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All of the RSUs will vest on January 1, 2021, subject to the terms and conditions of the award and the Company's 2018 Plan."}],"balance_after":3298,"derivative":{"underlying":"Common Stock","underlying_shares":3298},"source":{"system":"sec-edgar","filing":"0001209191-20-038661","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1664106/000120919120038661/doc4.xml","form_type":"4"}},{"id":3101474,"issuer":{"id":122292,"kind":"organization","name":"LogicBio Therapeutics, Inc.","symbol":"LOGC"},"owners":[{"id":67760,"kind":"person","name":"Chen Leon","position":1,"cik":"0001752432","reported_name":"Chen Leon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-23T20:00:15.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the options will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of LogicBio Therapeutics, Inc. (the \"Company\") 2021 Annual Meeting of Stockholders, subject to the terms and conditions of the award and the Company's 2018 Equity Incentive Plan (the \"2018 Plan\")."}],"balance_after":10000,"derivative":{"exercise_price":7.96,"expiration_date":"2030-06-19","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-038661","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664106/000120919120038661/doc4.xml","form_type":"4"}},{"id":3333508,"issuer":{"id":122292,"kind":"organization","name":"LogicBio Therapeutics, Inc.","symbol":"LOGC"},"owners":[{"id":67760,"kind":"person","name":"Chen Leon","position":1,"cik":"0001752432","reported_name":"Chen Leon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-12-20T20:00:15.000Z","date":"2019-12-19","kind":"grant","acquired":true,"shares":10869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vests on the earlier of 7/15/2020 or the 2020 Annual Meeting of Stockholders."}],"balance_after":10869,"derivative":{"exercise_price":12.65,"expiration_date":"2029-12-19","underlying":"Common Stock","underlying_shares":10869},"source":{"system":"sec-edgar","filing":"0001209191-19-061663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664106/000120919119061663/doc4.xml","form_type":"4"}},{"id":3785743,"issuer":{"id":122292,"kind":"organization","name":"LogicBio Therapeutics, Inc.","symbol":"LOGC"},"owners":[{"id":67760,"kind":"person","name":"Chen Leon","position":1,"cik":"0001752432","reported_name":"Chen Leon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-10-22T21:19:08.000Z","date":"2018-10-18","kind":"grant","acquired":true,"shares":24102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable in equal installments on each of the first three anniversaries of the grant date, October 18, 2018."}],"balance_after":24102,"derivative":{"exercise_price":10,"expiration_date":"2028-10-17","underlying":"Common Stock","underlying_shares":24102},"source":{"system":"sec-edgar","filing":"0000899243-18-027225","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664106/000089924318027225/doc4.xml","form_type":"4"}}]}